NanoRepro AG (ETR:NN6)
Germany
· Delayed Price · Currency is EUR 1.595
+0.025 (1.59%)
Apr 29, 2026, 12:08 PM CET
NanoRepro AG Revenue
NanoRepro AG had revenue of 2.43M EUR in the half year ending June 30, 2025, with 74.29% growth. This brings the company's revenue in the last twelve months to 5.17M, up 45.00% year-over-year. In the year 2024, NanoRepro AG had annual revenue of 4.51M with 41.68% growth.
Revenue (ttm)
5.17M
Revenue Growth
+45.00%
P/S Ratio
3.83
Revenue / Employee
245.99K
Employees
21
Market Cap
19.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.51M | 1.33M | 41.68% |
| Dec 31, 2023 | 3.18M | -35.61M | -91.79% |
| Dec 31, 2022 | 38.79M | -124.00M | -76.17% |
| Dec 31, 2021 | 162.79M | 145.86M | 861.58% |
| Dec 31, 2020 | 16.93M | 15.12M | 837.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.10B |
| Siemens Healthineers AG | 23.30B |
| Bayer Aktiengesellschaft | 45.58B |
| Fresenius SE & Co. KGaA | 22.87B |
| DocCheck AG | 55.32M |
| Pentixapharm Holding AG | 526.00K |
| MeVis Medical Solutions AG | 16.06M |
| aap Implantate AG | 12.16M |
NanoRepro AG News
- 6 days ago - NanoRepro raises its equity stake in Deutsche Kosmetikwerke: NanoRepro raises its stake in DKW to 43.72%. ... - Finanz Nachrichten
- 6 days ago - NanoRepro raises its equity stake in Deutsche Kosmetikwerke - Wallstreet:Online
- 7 days ago - From tests to brands, revamping NanoRepro; INITIATE with BUY - Wallstreet:Online